Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data

Overview of attention for article published in Cardiovascular Diabetology, July 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter: 43 X users

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 41 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 44 X posts from 43 X users, with an upper bound of 257,017 followers.

RT @kamleshkhunti: Our CVD-REAL study of nearly 900,000 people from 13 countries with T2 diabetes shows SGLT-2i associated with ⬇️ of Hea…

01 Sep 2021

Reply Repost Favourite

Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data. https://t.co/ewPlF7dsM4

31 Aug 2021

Reply Repost Favourite

Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data #HelsinkiHealth #tutkimus #tiede https://t.co/vI2ZDURYK4

12 Aug 2021

Reply Repost Favourite

RT @kamleshkhunti: Our CVD-REAL study of nearly 900,000 people from 13 countries with T2 diabetes shows SGLT-2i associated with ⬇️ of Hea…

05 Aug 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 40 additional X posts.